Results 181 to 190 of about 358,441 (297)

MR-Guided Laser Interstitial Thermal Therapy for Recurrent Glioblastoma: A Case Report With Novel Insights Into Histopathological Changes and Immunological Responses. [PDF]

Neuropathol Appl Neurobiol
Nielsen SH, Artzi SB, Skjøth-Rasmussen J, Larsen CC, Hammouda NM, Larsen KB, Rasmussen R, Hansen AE, Kristensen BW.   +8 more
europepmc   +1 more source

Glioblastoma

, 2019
Weller, M, Watts, Colin, Reardon, David A, Mehta, Minesh P   +3 more
openaire   +3 more sources

Consensus statement on microglial and macrophage functions in gliomas. [PDF]

Acta Neuropathol
Zheng Y, Alzoubi I, Graeber MB, Anand A, Barazzuol L, Dorostkar M, Frontzek K, Golebiewska A, Hadjipanayis CG, Hortobagyi T, Ismail A, Jansen GH, Kaminska B, Kirschenbaum D, Komohara Y, Kristensen BW, Lee KS, Le Rhun E, Lu QR, Matiasek K, Mawrin C, Michelucci A, Montemurro N, Mouthon MA, Liu Q, Reimann R, Sankowski R, Schcolnik-Cabrera A, Schulz M, Schürch CM, Schwabenland M, Tchoghandjian A, Valiulytė-Simaitė I, Viapiano MS, Weiss T, Weller M, Wintermark M.   +36 more
europepmc   +1 more source

Glioblastoma [PDF]

, 2020
openaire   +2 more sources

Glioblastoma Stem Cells and Tumour Microenvironment: Interactions Across Hypoxia, Vasculature and Immune Modulation. [PDF]

Int J Mol Sci
Biserova K, Strumfa I.
europepmc   +1 more source

UCHL1 promotes temozolomide resistance in glioblastoma by inhibiting the ubiquitination-mediated degradation of keratin 8. [PDF]

Transl Oncol
Zheng R, Chen X, Xu G, Liu Q, Hu S, Shi H, Zhu Z, Ding X, Zhang H, Wang W.   +9 more
europepmc   +1 more source

The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence [PDF]

, 2018
Badiyan, Shahed N, Cai, Chunyu, Huang, Jiayi, Khwaja, Shariq S, Wang, Xiaowei   +4 more
core   +1 more source

Plasma histone monomers as novel diagnostic markers in adult glioblastoma. [PDF]

J Liq Biopsy
Tsoneva DK, Buzova D, Todorova SM, Enchev Y, Frohlich J, Chaldakov GN, Tonchev AB, Cerveny J, Vinciguerra M.   +8 more
europepmc   +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Glutamate decarboxylase 1 (GAD1) suppresses the progression of glioblastoma through GSK3β/β-catenin pathway. [PDF]

Cell Death Discov
Zheng Y, Zhong Z, Zhang C, Gu J.
europepmc   +1 more source